These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34106495)

  • 1. Easily Available, Amphiphilic Diiron Cyclopentadienyl Complexes Exhibit in Vitro Anticancer Activity in 2D and 3D Human Cancer Cells through Redox Modulation Triggered by CO Release.
    Biancalana L; De Franco M; Ciancaleoni G; Zacchini S; Pampaloni G; Gandin V; Marchetti F
    Chemistry; 2021 Jul; 27(39):10169-10185. PubMed ID: 34106495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer Diiron Vinyliminium Complexes: A Structure-Activity Relationship Study.
    Braccini S; Rizzi G; Biancalana L; Pratesi A; Zacchini S; Pampaloni G; Chiellini F; Marchetti F
    Pharmaceutics; 2021 Jul; 13(8):. PubMed ID: 34452119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-Indolyl diiron vinyliminium complexes exhibit antiproliferative effects in cancer cells associated with disruption of mitochondrial homeostasis, ROS scavenging, and antioxidant activity.
    Bresciani G; Cervinka J; Kostrhunova H; Biancalana L; Bortoluzzi M; Pampaloni G; Novohradsky V; Brabec V; Marchetti F; Kasparkova J
    Chem Biol Interact; 2023 Nov; 385():110742. PubMed ID: 37802407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer Potential of Diiron Vinyliminium Complexes.
    Rocco D; Batchelor LK; Agonigi G; Braccini S; Chiellini F; Schoch S; Biver T; Funaioli T; Zacchini S; Biancalana L; Ruggeri M; Pampaloni G; Dyson PJ; Marchetti F
    Chemistry; 2019 Nov; 25(65):14801-14816. PubMed ID: 31441186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed-ligand Cu(II) hydrazone complexes designed to enhance anticancer activity.
    Mo Q; Deng J; Liu Y; Huang G; Li Z; Yu P; Gou Y; Yang F
    Eur J Med Chem; 2018 Aug; 156():368-380. PubMed ID: 30015073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent anticancer activity of photo-activated oxo-bridged diiron(III) complexes.
    Chanu SB; Banerjee S; Roy M
    Eur J Med Chem; 2017 Jan; 125():816-824. PubMed ID: 27750199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, characterization and biological evaluation of cationic organoruthenium(ii) fluorene complexes: influence of the nature of the counteranion.
    Haghdoost MM; Golbaghi G; Guard J; Sielanczyk S; Patten SA; Castonguay A
    Dalton Trans; 2019 Sep; 48(35):13396-13405. PubMed ID: 31432885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the anti-proliferative effects of novel DNA-intercalating bipyridyl-thiourea-Pt(II) complexes against cisplatin-sensitive and -resistant human ovarian cancer cells.
    Marverti G; Cusumano M; Ligabue A; Di Pietro ML; Vainiglia PA; Ferrari A; Bergomi M; Moruzzi MS; Frassineti C
    J Inorg Biochem; 2008 Apr; 102(4):699-712. PubMed ID: 18082268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The beneficial effect of cyclohexyl substituent on the
    Benetti S; Dalla Pozza M; Biancalana L; Zacchini S; Gasser G; Marchetti F
    Dalton Trans; 2023 May; 52(17):5724-5741. PubMed ID: 37038773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlling the Reactivity of Bifunctional Ligands: Carboxylate-Bridged Nonheme Diiron(II) Complexes Bearing Free Thiol Groups.
    Pal N; Majumdar A
    Inorg Chem; 2016 Mar; 55(6):3181-91. PubMed ID: 26959857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrochemical, mechanistic, and DFT studies of amine derived diphosphines containing Ru(II)-cymene complexes with potent
    da Silva JP; Fuganti O; Kramer MG; Facchin G; Aquino LEN; Ellena J; Back DF; Gondim ACS; Sousa EHS; Lopes LGF; Machado S; Guimarães IDL; Wohnrath K; de Araujo MP
    Dalton Trans; 2020 Nov; 49(45):16498-16514. PubMed ID: 33206073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific Conformational Change in Giant DNA Caused by Anticancer Tetrazolato-Bridged Dinuclear Platinum(II) Complexes: Middle-Length Alkyl Substituents Exhibit Minimum Effect.
    Komeda S; Yoneyama H; Uemura M; Muramatsu A; Okamoto N; Konishi H; Takahashi H; Takagi A; Fukuda W; Imanaka T; Kanbe T; Harusawa S; Yoshikawa Y; Yoshikawa K
    Inorg Chem; 2017 Jan; 56(2):802-811. PubMed ID: 28045514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.
    Bakalova AG; Buyukliev RT; Nikolova RP; Shivachev BL; Mihaylova RA; Konstantinov SM
    Anticancer Agents Med Chem; 2019; 19(10):1243-1252. PubMed ID: 30767754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents.
    Yang Y; Guo L; Tian Z; Gong Y; Zheng H; Zhang S; Xu Z; Ge X; Liu Z
    Inorg Chem; 2018 Sep; 57(17):11087-11098. PubMed ID: 30133276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The synthesis, characterisation and reactivity of 2-phosphanylethylcyclopentadienyl complexes of cobalt, rhodium and iridium.
    McConnell AC; Pogorzelec PJ; Slawin AM; Williams GL; Elliott PI; Haynes A; Marr AC; Cole-Hamilton DJ
    Dalton Trans; 2006 Jan; (1):91-107. PubMed ID: 16357965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel C,N-Cyclometalated Benzimidazole Ruthenium(II) and Iridium(III) Complexes as Antitumor and Antiangiogenic Agents: A Structure-Activity Relationship Study.
    Yellol J; Pérez SA; Buceta A; Yellol G; Donaire A; Szumlas P; Bednarski PJ; Makhloufi G; Janiak C; Espinosa A; Ruiz J
    J Med Chem; 2015 Sep; 58(18):7310-27. PubMed ID: 26313136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparative Analysis of the In Vitro Anticancer Activity of Iridium(III) {η
    De Palo A; Draca D; Murrali MG; Zacchini S; Pampaloni G; Mijatovic S; Maksimovic-Ivanic D; Marchetti F
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triiron Complex with
    Saviozzi C; Biancalana L; Funaioli T; Bortoluzzi M; De Franco M; Guelfi M; Gandin V; Marchetti F
    Inorg Chem; 2024 Jan; 63(2):1054-1067. PubMed ID: 38166407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trans-[bis(benzimidazol-2-ylidene)dichlorido]platinum(II) complexes with peculiar modes of action and activity against cisplatin-resistant cancer cells.
    Bär SI; Schleser SW; Oberhuber N; Herrmann A; Schlotte L; Weber SE; Schobert R
    J Inorg Biochem; 2023 Jan; 238():112028. PubMed ID: 36274479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
    Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
    Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.